Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 1, 1994
A note on distribution of human plasma levels of ascorbic and dehydroascorbic acidM Capellmann, M Becka, H M Bolt
The Journal of International Medical Research|December 5, 2012
Absence of clinically relevant interactions between rivaroxaban--an oral, direct Factor Xa inhibitor--and digoxin or atorvastatin in healthy subjectsD Kubitza, M Becka, A Roth, et al.
Parasitology Research|December 3, 2005
Isospora suis: an experimental model for mammalian intestinal coccidiosisH-C Mundt, A Joachim, M Becka, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 29, 2007
Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjectsW Mueck, M Becka, D Kubitza, et al.
Journal of the International Association of Providers of AIDS Care|November 2, 2014
Lack of knowledge about mother-to-child HIV transmission prevention in pregnant women at Tijuana General Hospital, Baja California, MexicoChandra M Becka, Enrique Chacón-Cruz, Maria Rosario Araneta, et al.
Regulatory Toxicology and Pharmacology : RTP|May 12, 2000
Quantitative distribution studies in animals: cross-validation of radioluminography versus liquid-scintillation measurementW Steinke, Y Archimbaud, M Becka, et al.
Clinical Biochemistry|February 29, 2000
Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1 analyzerT Ropers, W Kroll, M Becka, et al.
Archives of Toxicology|May 17, 2001
Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamideP Andrews, A Freyberger, E Hartmann, et al.
Journal of Thrombosis and Haemostasis : JTH|August 15, 2017
Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover studyR Kreutz, P B Persson, D Kubitza, et al.
Therapeutic Advances in Infectious Disease|March 21, 2019
Severe mycotic keratoconjunctivitis caused by Fusarium sp. in an immunocompetent child successfully treated with intravenous voriconazole and keratoplasty: case report and short review of the literatureEnrique Chacon-Cruz, Francisco Male-Valle, Rosa M Rivas-Landeros, et al.
Pageof 2